Stephan Schann

Company: Domain Therapeutics

Job title: Chief Scientific Officer

Seminars:

MC4R Pharmacochaperone as a Novel Therapeutic Strategy for Genetic Forms of Early-Onset Obesity 11:30 am

MC4R mutations resulting in receptor trafficking default as the cause of early onset obesity Therapeutic use of small molecule pharmacochaperones to rescue plasma membrane trafficking of MC4R Presentation of an unique toolbox made of in vitro and genetic in vivo models, and of in vivo proof-of-concept dataRead more

day: Conference Day One